Thromboembolic Complications in
Myelomatosis SIR,-I was very interested in the article by Dr. D. Catovsky and others drawing attention to the thromboembolic complications in myelomatosis (22 August, p. 438) . It is becoming apparent that thromboembolic complications in this disease are more common than has been hitherto believed, although the views of Sanchez-Avalos et a.' that they are nearly as common as the haemorrhagic complications appear to be an over-estimate. This is supported by a number of recent studies in which thromboembolism had not been mentioned, while haemorrhagic complications featured prominently,2-5 as well as by personal observations, the incidence of haemorrhagic complications being twice as high as that of thromboembolism.6
As to the role of amyloidosis in causation of these complications the position appears to be less clear. 
